Trial
NCT02624479
Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
—
Condition
Healthy
Intervention
Sodium thiosulfate
Why stopped
Formulations could never be successfully produced
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-09